07 Jan 2001

Rovamycine (spiramycine) - Nederland

Updated: 07 Jan 2001

Rovamycine

Luchtweginfecties door voor spiramycine gevoelige micro- organismen.

Rovamycine Description, Presentation and Dosage

Rovamycine Description

Rovamycine Drug Class Description

Volwassenen: eerste dag 1500 mg tweemaal per dag; volgende dagen 1 g tweemaal per dag. Kinderen: 50-100 mg/kg lichaamsgewicht per dag in 2-4 doses.

Rovamycine Drug Description

Bacteriostatisch antibioticum. Het spectrum omvat o.a. streptokokken en stafylokokken en de Gram-negatieve organismen Haemophilus influenza, Neisseria gonorrhoeae en meningitidis en Bordetella pertussis. Spiramycine ontplooit de grootste werkzaamheid in alkalisch milieu. Kinetische gegevens: Resorptie: onvolledig, vooral bij kinderen. Tmax = ca 2 uur. Penetreert goed in de weefsels; deze concentraties kunnen meer dan tienmaal zo hoog zijn als de bloedspiegels. Passeert de bloed- hersenbarriere niet. Eliminatie: vnl. via speeksel en gal; via de urine max. 10%. Plasmahalfwaardetijd = 3-4 uur.

Rovamycine Generic Name

spiramycine

Rovamycine Presentation

Rovamycine Presentation

Tablet 500 mg.

Rovamycine Manufacturer

RPR

Related Learning Zones

CLL Knowledge Centre and CME

CLL Knowledge Centre and CME

The Chronic Lymphocytic Leukaemia (CLL) Knowledge Centre contains useful information arranged within four main sections: ‘Disease Awareness’, ‘Events’, ‘Resources’, and 'CME'. Healthcare professionals will find information on pathophysiology, signs and symptoms of CLL, diagnosis, prognosis, treatment and management options, an upcoming events calendar and an external links listing,

The CME activity ‘Treatment Optimisation in Chronic Lymphocytic Leukaemia’ has been EACCME-accredited and awarded 1 CME credit. Test your knowledge by answering quiz questions based on patient case study scenarios.

LAL-D Knowledge Centre

LAL-D Knowledge Centre

The Lysosomal Acid Lipase (LAL) Deficiency Knowledge Centre contains a range of accurate, informative clinical content for healthcare professionals. The disease awareness section presents epidemiology, pathophysiology and diagnosis information, among others. The treatment section details the drug characteristics, safety and efficacy of sebelipase alfa – the first and only licenced treatment for LAL deficiency. The resources section contains further clinical content including a video channel presenting expert opinions on diagnostic approach and current prognosis.

Developed by EPG Health Media (Europe) Ltd for epgonline.org, in collaboration and with content provided by Alexion Pharma GmbH

Rovamycine Dosage

Rovamycine Child Dosage

Spiramycine kan, voor zover bekend zonder gevaar voor de vrucht, overeenkomstig het voorschrift worden gebruikt tijdens zwangerschap.

Rovamycine Precautions, Reactions and Contraindications

Rovamycine Special Precautions

Rovamycine Special Precautions

Er bestaat kruisresistentie tussen de macroliden onderling en met antimicrobiele middelen van de lincomycinengroep.

Rovamycine Adverse Reactions

Rovamycine Adverse Reactions

Lichte gastro-intestinale stoornissen, exanthemen. Overgevoeligheid kan voorkomen.

Rovamycine Contraindications

Rovamycine Contraindications

Overgevoeligheid voor macroliden.

Related Drugs - Infectious Diseases

Back to top